Chargement en cours...
Current and Future Treatment Strategies for Rhabdomyosarcoma
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children, and can be subcategorized histologically and/or based on PAX-FOXO1 fusion gene status. Over the last four decades, there have been no significant improvements in clinical outcomes for advanced and metastatic RMS patients, und...
Enregistré dans:
| Publié dans: | Front Oncol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6933601/ https://ncbi.nlm.nih.gov/pubmed/31921698 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01458 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|